Supreme Court
Reclassification of Ephedrine and Pseudoephedrine
Ddb Board Regulation No. 4
The Dangerous Drugs Board in the Philippines reclassifies Ephedrine and Pseudoephedrine as dangerous drugs, with exemptions for certain preparations that meet specific criteria, and imposes restrictions on their sale, distribution, and advertising.
END